Peer-reviewed article: Numaswitch: An efficient high-titer expression platform to produce peptides and small proteins

“The production of peptides as active pharmaceutical ingredients (APIs) by recombinant technologies is of emerging interest. A reliable production platform, however, is still missing due to the inherent characteristics of peptides such as proteolytic sensitivity, aggregation and cytotoxicity. We have developed a new technology named Numaswitch
solving present limitations.”